Ignite Creation Date:
2024-05-06 @ 12:04 AM
Last Modification Date:
2024-10-26 @ 10:44 AM
Study NCT ID:
NCT01482767
Status:
COMPLETED
Last Update Posted:
2021-11-04
First Post:
2011-11-28
Brief Title:
Evaluating the Effectiveness of Boceprevir Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus HCV Infection in Adults With HIV and HCV Infection
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Organization Data
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Class:
NIH
Study ID:
A5294 BIRTH
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None